Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should Investors Worry About Moderna's European Vaccine Delivery Delay?

TheMotleyFool

0 0

Should Investors Worry About Moderna's European Vaccine Delivery Delay?: https://g.foolcdn.com/editorial/images/683110/vaccine-being-given-to-a-young-man.jpg

Moderna's (NASDAQ: MRNA) second quarter might not be as strong as expected. The company announced today that it has reached an agreement with the European Commission to revise the contractual delivery schedules for shipping its COVID-19 vaccine boosters. Booster doses scheduled for delivery in Q2 will now likely be pushed back to the second half of 2022 or even into early 2023.

The vaccine stock was down 6.5% as of 10:45 a.m. ET on Thursday on the news. Should investors worry about Moderna's European vaccine delivery delay?

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share